3Crawford ED,Eisenberger MA,Mcleod DG,et al.A controlled trial of leuprolide with and without flutamide in prostatic carcinoma[J].N Engl J Med,1989,321:419-424.
4Raghavan D,Brandes LJ,Klapp K,et al.Phase Ⅱ trial of tesmilifene plus mitoxantrone and prednisone for hormne refractory prostate cancer:High subjective and objective response in patients with symptomatic metastases[J].J Urol,2005,174:1808-1813.
5Kantoff PW,Halabi S,Conaway M,et al.Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer:Results of the cancer and leukemia group B 9182 study[J].J Clin Oncol,1999,17(8):2506-2513.
6Bubley GJ,Carducci M,Dahut W,et al.Eligibility and response guidelines for phase Ⅱ clinical trials in androgen-independent prostate cancer:recommendations from the Prostate-Specific Antigen Working Group[J].J Clin Oncol,1999,17:3461-3467.
7Tannock IF,deWit R,Berry WJ,et al.Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer[J].N Engl J Med,2004,351:1502-1512.
8Petrylak DP,Tangen CM,Hussain MH,et al.Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer[J].N Engl J Med,2004,351:1513-1520.
9Sella A,Yarom N,Zisman A,et al.Paclitaxel,estramustine and carboplatin combination chemotherapy after initial docetaxel-based chemotherapy in castration-resistant prostate cancer[J].Oncology,2009,76(6):442-446.
10Mottet N, Bellmunt J, Bolla M, et ah EAU gu tate cancer. Part Ⅱ: Treatment of advanced, rel idelines on pros- apsing, and cas- 2011. 59, 572-583.
